An oral, small-molecule inhibitor of FLT3 for the treatment of AML (acute myelogenous leukemia) and other cancer indications. The drug exhibited limited activity as a single agent in phase I and II clinical trials in patients with AML and myelodysplastic syndrome, but displayed promising antileukemic activity (90% complete remissions) in a phase I/II trial in patients with newly diagnosed AML when administered in combination with cytarabine and daunorubicin.
Payment
eBioChem Escrow service is especially designed for online transaction. You, as a buyer, will pay the Supplier ONLY after you receive the item(s) and are satisfied with the item(s). This value-added service is absolutely FREE and is available for all transactions at eBioChem.com.
Payment Method
Alipay:
Alipay can support the domestic Union pay card with RMB payment
payPal:
Credit Card:
Paypal can support all of the foreign credit card payment
